12:39 Dec 05

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2098.80
+6.80 (+0.33%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lupin Ltd. Financials

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2098.80
+6.80 (+0.33%)
12:39 Dec 05
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

64/100
Technically Moderately Bullish

Strength

19

Weakness

1

Opportunity

1

Threats

0

19.07 %

ROE %

11.23 %

ROA %

94.68

EPS

376.77

BVPS

14.45 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
16405.48 16641.66 20010.82 22707.9 23375.91
Operating Expenses +
16118.26 14843.54 16200.3 17424.59 17631.24
Raw Material
6679.56 6626.03 7100.91 7100.03 7154.31
Increase Decrease in Cost
-198.32 153.73 -457.44 -257.78 -284.69
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2989.3 3087.15 3494.57 3964.2 4076.16
Miscellaneous Expenses
13535.42 10853.07 11979.7 11903.38 6685.46
Operating Profit
287.22 1798.12 3810.52 5283.31 5744.67
Other Income
141.69 73.36 120.17 195.82 231.99
Depreciation
1658.71 880.69 1196.81 1169.26 1220.53
Interest
142.77 274.3 311.61 294.87 318.62
Profit before tax and exceptio..
-1372.57 716.49 2422.27 4015 4437.51
Exceptional Items
0 0 0 0 0
PBT
-1372.57 716.49 2422.27 4015 4437.51
Provision for Taxation
137.15 268.8 486.7 708.74 715.33
Net Profit
-1509.72 447.69 1935.57 3306.26 3722.18
NET Profit after MI
-1528.04 430.08 1914.48 3281.62 3699.34
EPS
-33.65 9.41 41.87 71.95 81.08
Operating Profit Margin (%)
1.75 10.8 19.04 23.27 24.58
Net Profit Margin (%)
-9.31 2.58 9.57 14.45 15.83

Lupin Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 46.90 46.90 46.90 47.00 47.00 47.00
FII 20.50 21.20 21.50 22.00 21.50 19.30
Public 26.60 25.60 25.40 24.80 25.10 26.80
Others 6.00 6.30 6.20 6.20 6.40 6.90
Shareholder Shares Holding %
Download Our App On: